Cargando…
Cell-based treatment for perinatal hypoxic-ischemic encephalopathy
Hypoxic-ischemic encephalopathy (HIE) is a major cause of acute neonatal brain injury and can lead to disabling long-term neurological complications. Treatment for HIE is limited to supportive care and hypothermia within 6 h injury which is reserved for full-term infants. Preclinical studies suggest...
Autores principales: | Park, You Jeong, Borlongan, Cesario V., Dezawa, Mari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057102/ https://www.ncbi.nlm.nih.gov/pubmed/34084971 http://dx.doi.org/10.4103/bc.bc_7_21 |
Ejemplares similares
-
Perinatal Hypoxic-Ischemic Encephalopathy
por: Lai, Ming-Chi, et al.
Publicado: (2011) -
Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy
por: Suzuki, Toshihiko, et al.
Publicado: (2020) -
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
por: Taniguchi, Hidetoshi, et al.
Publicado: (2008) -
Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy
por: Gonzales-Portillo, Gabriel S., et al.
Publicado: (2014) -
Actualities on molecular pathogenesis and repairing processes of cerebral damage in perinatal hypoxic-ischemic encephalopathy
por: Distefano, Giuseppe, et al.
Publicado: (2010)